Environmental intervention for house dust mite control in childhood bronchial asthma

Engy M El-Ghitany1, Magda M Abd El-Salam

  • 1Tropical Health Department, High Institute of Public Health, Alexandria University, Egypt. ingy.elghitany@gmail.com

Abstract

Insights

Physical control measures significantly improved asthma symptoms in children sensitive to house dust mites (HDM). Combined physical and chemical interventions also showed positive results, offering effective strategies for asthma management.

Area of Science:

  • Environmental Health
  • Pediatric Allergy
  • Respiratory Medicine

Background:

  • House dust mites (HDM) are a common allergen triggering asthma in children.
  • Effective environmental control is crucial for managing pediatric asthma.
  • Previous interventions have shown variable success in mitigating HDM-induced asthma symptoms.

Purpose of the Study:

  • To evaluate the efficacy of physical and chemical environmental controls for HDM in managing childhood asthma.
  • To compare the effectiveness of physical, chemical, and combined interventions against a control group.

Main Methods:

  • 160 asthmatic children sensitized to HDM were enrolled.
  • Participants were randomized into four groups: physical, chemical, combined, or no intervention.
  • Clinical outcomes and environmental factors were assessed at 8 and 16 weeks.

Main Results:

  • Physical control measures led to significant improvements in lung function (FEV1, PEFR) and reduced severe asthma cases.
  • Combined physical and chemical (tannic acid) interventions also demonstrated significant positive effects.
  • Chemical intervention alone showed a reduction in moderate and severe asthma cases, though less pronounced than physical or combined methods.

Conclusions:

  • Simple physical control measures are effective in managing asthma symptoms in children allergic to HDM.
  • Combined physical and chemical strategies offer a potent approach to asthma control.
  • Environmental modification plays a vital role in the therapeutic management of allergic asthma.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...